BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27029442)

  • 1. [The dynamics of psychopathological symptoms of ultra high risk for psychosis in young patients with non-psychotic mental disorders].
    Omel'chenko MA; Rumyantsev AO; Kaleda VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):16-21. PubMed ID: 27029442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognitive insight and dynamics of indicators of ultra-high risk for schizophrenia in young patients with non-psychotic forms of mental disorders].
    Rasskazova EI; Omel Chenko MA; Rumyantsev AO; Kaleda VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):9-16. PubMed ID: 27635605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
    Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychopathology and outcome in first-admission schizophrenia: a 13-year follow-up study at a medical school hospital].
    Kobayashi T
    Seishin Shinkeigaku Zasshi; 2001; 103(5):383-410. PubMed ID: 11510079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.
    Carpenter WT; Bustillo JR; Thaker GK; van Os J; Krueger RF; Green MJ
    Psychol Med; 2009 Dec; 39(12):2025-42. PubMed ID: 19796428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
    Mittal VA; Neumann C; Saczawa M; Walker EF
    Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of manifestation of endogenous psychosis in patients with nonpsychotic mental disorders of juvenile age].
    Omel'chenko MA; Golubev SA; Nikiforova IIu; Kaleda VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(6):14-20. PubMed ID: 25042485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders.
    Fenton WS; McGlashan TH; Victor BJ; Blyler CR
    Am J Psychiatry; 1997 Feb; 154(2):199-204. PubMed ID: 9016268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the continuum of psychosis: Frequency and characteristics of psychotic-like symptoms in relatives and non-relatives of patients with schizophrenia.
    Landin-Romero R; McKenna PJ; Romaguera A; Álvarez-Moya E; Sarró S; Aguirre C; Sarri C; Compte A; Bosque C; Salvador R; Pomarol-Clotet E
    Schizophr Res; 2016 Dec; 178(1-3):6-11. PubMed ID: 27632907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].
    Demily C; Jacquet P; Marie-Cardine M
    Encephale; 2009 Apr; 35(2):139-45. PubMed ID: 19393382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the descriptive validity of ICD-10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses.
    Jäger M; Bottlender R; Strauss A; Möller HJ
    Psychopathology; 2003; 36(3):152-9. PubMed ID: 12845286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset schizophrenia: a 15-year follow-up.
    Röpcke B; Eggers C
    Eur Child Adolesc Psychiatry; 2005 Sep; 14(6):341-50. PubMed ID: 16220219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics of initial stages of schizotypal disorder].
    Ivanets NN; Efremova EN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):23-6. PubMed ID: 22810736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.